1565 related articles for article (PubMed ID: 19022235)
1. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
2. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
3. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.
Smuc T; Rizner TL
Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784
[TBL] [Abstract][Full Text] [Related]
4. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).
Fournier MA; Poirier D
Mol Cell Endocrinol; 2009 Mar; 301(1-2):142-5. PubMed ID: 18817841
[TBL] [Abstract][Full Text] [Related]
5. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
6. Estrogen inhibits cell proliferation through in situ production in human thymoma.
Ishibashi H; Suzuki T; Suzuki S; Moriya T; Kaneko C; Nakata T; Sunamori M; Handa M; Kondo T; Sasano H
Clin Cancer Res; 2005 Sep; 11(18):6495-504. PubMed ID: 16166425
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer.
Smuc T; Rupreht R; Sinkovec J; Adamski J; Rizner TL
Mol Cell Endocrinol; 2006 Mar; 248(1-2):114-7. PubMed ID: 16337331
[TBL] [Abstract][Full Text] [Related]
8. New development in intracrinology of breast carcinoma.
Sasano H; Suzuki T; Nakata T; Moriya T
Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
[TBL] [Abstract][Full Text] [Related]
9. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis.
Smuc T; Pucelj MR; Sinkovec J; Husen B; Thole H; Lanisnik Rizner T
Gynecol Endocrinol; 2007 Feb; 23(2):105-11. PubMed ID: 17454161
[TBL] [Abstract][Full Text] [Related]
11. Estrogen metabolizing enzymes in endometrium and endometriosis.
Dassen H; Punyadeera C; Kamps R; Delvoux B; Van Langendonckt A; Donnez J; Husen B; Thole H; Dunselman G; Groothuis P
Hum Reprod; 2007 Dec; 22(12):3148-58. PubMed ID: 17921479
[TBL] [Abstract][Full Text] [Related]
12. Progestins and breast cancer.
Pasqualini JR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
[TBL] [Abstract][Full Text] [Related]
13. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.
Aka JA; Mazumdar M; Lin SX
Mol Cell Endocrinol; 2009 Mar; 301(1-2):183-90. PubMed ID: 19038308
[TBL] [Abstract][Full Text] [Related]
14. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
Hevir-Kene N; Rižner TL
Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
[TBL] [Abstract][Full Text] [Related]
15. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
[TBL] [Abstract][Full Text] [Related]
16. Steroid metabolism in breast cancer.
Foster PA
Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
Xu B; Kitawaki J; Koshiba H; Ishihara H; Kiyomizu M; Teramoto M; Kitaoka Y; Honjo H
Maturitas; 2007 Feb; 56(2):142-52. PubMed ID: 16962266
[TBL] [Abstract][Full Text] [Related]
18. Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function.
Janssen JM; Bland R; Hewison M; Coughtrie MW; Sharp S; Arts J; Pols HA; van Leeuwen JP
J Cell Biochem; 1999 Dec; 75(3):528-37. PubMed ID: 10536374
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer.
Irahara N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2006 Nov; 243(1):23-31. PubMed ID: 16556483
[TBL] [Abstract][Full Text] [Related]
20. 17beta-hydroxysteroid dehydrogenases in human breast cancer.
Nagasaki S; Miki Y; Akahira J; Suzuki T; Sasano H
Ann N Y Acad Sci; 2009 Feb; 1155():25-32. PubMed ID: 19250189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
